Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
67.5 EUR | +1.50% |
|
+1.50% | -2.88% |
Jul. 10 | UBS Cuts Cohen & Steers' Price Target to $63 From $65, Sell Rating Maintained | MT |
Jul. 09 | Cohen & Steers Preliminary AUM Rise in June | MT |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- With a 2024 P/E ratio at 25.1 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.88% | 3.7B | - | ||
+32.11% | 97.13B | C+ | ||
-5.09% | 94.34B | C- | ||
+16.67% | 27.63B | B- | ||
-7.65% | 17.58B | - | B+ | |
+1.99% | 14.94B | C+ | ||
+6.09% | 14.26B | B | ||
-24.64% | 11.81B | C+ | ||
+30.58% | 10.64B | B | ||
+15.64% | 8.97B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CNS Stock
- FG9 Stock
- Ratings Cohen & Steers, Inc.